Is latent tuberculosis infection challenging in Iranian health care workers? A systematic review and meta-analysis


Autoři: Mohammad Hossein YektaKooshali aff001;  Farahnaz Movahedzadeh aff003;  Ali Alavi Foumani aff002;  Hoda Sabati aff005;  Alireza Jafari aff002
Působiště autorů: Student Research Committee, School of nursing, Midwifery and Paramedicine, Guilan University of Medical Sciences, Rasht, Iran aff001;  Inflammatory Lung Diseases Research Center, Department of Internal Medicine, Razi Hospital, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran aff002;  Institute for Tuberculosis Research, College of Pharmacy, University of Illinois at Chicago, Chicago, Illinois, United States of America aff003;  Department of pharmaceutical Sciences, College of Pharmacy University of Illinois at Chicago, Chicago, Illinois, United States of America aff004;  Biotechnology and Biological Science Research Center, Faculty of Science, Shahid Chamran University of Ahvaz, Ahvaz, Iran aff005;  Urology Research Center, Department of Internal Medicine, Razi Hospital, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran aff006
Vyšlo v časopise: PLoS ONE 14(10)
Kategorie: Research Article
doi: 10.1371/journal.pone.0223335

Souhrn

Background

The high chances of getting latent tuberculosis infection (LTBI) among health care workers (HCWs) will an enormous problem in low and upper-middle-income countries.

Method

Search strategies were done through both national and international databases include SID, Barakat knowledge network system, Irandoc, Magiran, Iranian national library, web of science, Scopus, PubMed/MEDLINE, OVID, EMBASE, the Cochrane library, and Google Scholar search engine. The Persian and the English languages were used as the filter in national and international databases, respectively. Medical Subject Headings (MeSH) terms was used to controlling comprehensive vocabulary. The search terms were conducted without time limitation till January 01, 2019.

Results

The prevalence of LTBI in Iranian’s HCWs, based on the PPD test was 27.13% [CI95%: 18.64–37.7]. The highest prevalence of LTBI in Iranian’s HCWs were estimated 41.4% [CI95%: 25.4–59.5] in the north, and 33.8% [CI95%: 21.1–49.3] in the west. The lowest prevalence of LTBI was evaluated 18.2% [CI95%: 3.4–58.2] in the south of Iran. The prevalence of LTBI in Iranian’s HCWs who had work-experience more than 20 years old were estimated 20.49% [CI95%: 11–34.97]. In the PPD test, the prevalence of LTBI in Iranian’s HCWs who had received the Bacille Calmette–Guérin (BCG) was estimated 15% [CI95%: 3.6–47.73]. While, in the QFT, the prevalence of LTBI in Iranian’s HCWs in non-vaccinated was estimated 25.71% [CI95%: 13.96–42.49].

Conclusions

This meta-analysis shows the highest prevalence of LTBI in Iranian’s HCWs in the north and the west probably due to neighboring countries like Azerbaijan and Iraq, respectively. It seems that Iranian’s HCWs have not received the necessary training to prevent of TB. We also found that BCG was not able to protect Iranian’s HCWs from TB infections, completely.

Klíčová slova:

Database searching – Iran – Metaanalysis – Mycobacterium tuberculosis – Systematic reviews – Tuberculosis – Historical geography – Skin tests


Zdroje

1. Apriani L, McAllister S, Sharples K, Alisjahbana B, Ruslami R, Hill PC, et al. Latent tuberculosis infection in healthcare workers in low- and middle-income countries: an updated systematic review. The European respiratory journal. 2019;53(4). Epub 2019/02/23. doi: 10.1183/13993003.01789-2018 30792341.

2. Korbel DS, Schneider BE, Schaible UE. Innate immunity in tuberculosis: myths and truth. Microbes Infect. 2008;10(9):995–1004. Epub 2008/09/03. doi: 10.1016/j.micinf.2008.07.039 18762264.

3. North RJ, Jung YJ. Immunity to tuberculosis. Annu Rev Immunol. 2004;22:599–623. Epub 2004/03/23. doi: 10.1146/annurev.immunol.22.012703.104635 15032590.

4. Russell DG. Who puts the tubercle in tuberculosis? Nat Rev Microbiol. 2007;5(1):39–47. Epub 2006/12/13. doi: 10.1038/nrmicro1538 17160001.

5. De Chastellier C. The many niches and strategies used by pathogenic mycobacteria for survival within host macrophages. Immunobiology. 2009;214(7):526–42. doi: 10.1016/j.imbio.2008.12.005 19261352

6. Davis JM, Ramakrishnan L. The role of the granuloma in expansion and dissemination of early tuberculous infection. Cell. 2009;136(1):37–49. Epub 2009/01/13. doi: 10.1016/j.cell.2008.11.014 19135887.

7. Houben RM, Dodd PJ. The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling. PLoS Med. 2016;13(10):e1002152. Epub 2016/10/26. doi: 10.1371/journal.pmed.1002152 27780211.

8. Azizi F, Hatami H, Janghorbani MJTEP. Epidemiology and control of common diseases in Iran. Tehran: Eshtiagh Publications. 2000:602–16.

9. Joshi R, Reingold AL, Menzies D, Pai MJPm. Tuberculosis among health-care workers in low-and middle-income countries: a systematic review. PLoS Med. 2006;3(12):e494. doi: 10.1371/journal.pmed.0030494 17194191

10. Kassim S, Zuber P, Wiktor S, Diomande F, Coulibaly I, Coulibaly D, et al. Tuberculin skin testing to assess the occupational risk of Mycobacterium tuberculosis infection among health care workers in Abidjan, Cote d'Ivoire. Int J Tuberc Lung Dis. 2000;4(4):321–6. 10777080

11. Nosocomial TJIJT. Nosocomial tuberculosis in the era of drug resistant tuberculosis. Emerg Infect Dis. 2009; 56:59–61.

12. Yanai H, Limpakarnjanarat K, Uthaivoravit W, Mastro T, Mori T, Tappero J JTIJoT, et al. Risk of Mycobacterium tuberculosis infection and disease among health care workers, Chiang Rai, Thailand. Int J Tuberc Lung Dis. 2003;7(1):36–45. 12701833

13. Field MJ, editor. Tuberculosis in the Workplace. Washington (DC): National Academies Press (US); 2001. C, The Occupational Tuberculosis Risk of Health Care Workers. https://www.ncbi.nlm.nih.gov/books/NBK222462/

14. Azami M, Sayehmiri K, YektaKooshali MH, HafeziAhmadi MR. The prevalence of tuberculosis among Iranian elderly patients admitted to the infectious ward of hospital: A systematic review and meta-analysis. Int J Mycobacteriol. 2016;5:S199–S200. https://doi.org/10.1016/j.ijmyco.2016.11.022. 28043551

15. Christopher DJ, Daley P, Armstrong L, James P, Gupta R, Premkumar B, et al. Tuberculosis infection among young nursing trainees in South India. PLoS ONE. 2010;5(4):e10408. doi: 10.1371/journal.pone.0010408 20454447

16. Garber E, San Gabriel P L L, Saiman L. A survey of latent tuberculosis infection among laboratory healthcare workers in New York City. Infection Control & Hospital Epidemiology. 2003;24(11):801–6.

17. Jo K-W, Hong Y, Park JS, Bae I-G, Eom JS, Lee S-R, et al. Prevalence of latent tuberculosis infection among health care workers in South Korea: a multicenter study. Tuberc Respir Dis (Seoul)2013;75(1):18–24. doi: 10.4046/trd.2013.75.1.18 23946754.

18. Brock I, Weldingh K, Lillebaek T, Follmann F, Andersen P. Comparison of tuberculin skin test and new specific blood test in tuberculosis contacts. Am J Respir Crit Care Med. 2004;170(1):65–9. Epub 2004/04/17. doi: 10.1164/rccm.200402-232OC 15087297.

19. Kang YA, Lee HW, Yoon HI, Cho B, Han SK, Shim Y-S, et al. Discrepancy between the tuberculin skin test and the whole-blood interferon γ assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country. JAMA. 2005;293(22):2756–61. doi: 10.1001/jama.293.22.2756 15941805

20. Mori T, Sakatani M, Yamagishi F, Takashima T, Kawabe Y, Nagao K, et al. Specific detection of tuberculosis infection: an interferon-γ–based assay using new antigens. Am J Respir Crit Care Med. 2004;170(1):59–64. doi: 10.1164/rccm.200402-179OC 15059788

21. Bennett JE, Dolin R, Blaser MJ. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases: 2-Volume Set: Elsevier Health Sciences; 2014.

22. Menzies DJCID. What does tuberculin reactivity after bacille Calmette-Guérin vaccination tell us? Clin Infect Dis. 2000;31(Supplement_3):S71–S4.

23. Menzies R, Vissandjee B. Effect of bacille Calmette-Guerin vaccination on tuberculin reactivity. Am Rev Respir Dis. 1992;145(3):621–5. Epub 1992/03/01. doi: 10.1164/ajrccm/145.3.621 1546843.

24. Gazi MA, Islam MR, Kibria MG, Mahmud Z JEJoCM, Diseases I. General and advanced diagnostic tools to detect Mycobacterium tuberculosis and their drug susceptibility: a review. Eur J Clin Microbiol Infect Dis. 2015;34(5):851–61. doi: 10.1007/s10096-014-2306-5 25560709.

25. Nasehi M, Hashemi-Shahraki A, Doosti-Irani A, Sharafi S, Mostafavi E JE, health. Prevalence of latent tuberculosis infection among tuberculosis laboratory workers in Iran. Epidemiol Health. 2017;30(39): e2017002. doi: 10.4178/epih.e2017002 28092930.

26. Liberati A, Taricco MJRiP, Books RMPMF. How to do and report systematic reviews and meta-analysis. 2010:137–64.

27. Cook DJ, Mulrow CD, Haynes RB. Systematic reviews: synthesis of best evidence for clinical decisions. Ann Intern Med. 1997;126(5):376–80. Epub 1997/03/01. doi: 10.7326/0003-4819-126-5-199703010-00006 9054282.

28. Moher D, Liberati A, Tetzlaff J, Altman DG JAoim. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264–9. doi: 10.7326/0003-4819-151-4-200908180-00135 19622511

29. Editors PLM. Best practice in systematic reviews: the importance of protocols and registration. PLoS Med. 2011;8(2):e1001009. Epub 2011/03/03. doi: 10.1371/journal.pmed.1001009 21364968.

30. Nasiri MJ, Pormohammad A, Goudarzi H, Mardani M, Zamani S, Migliori GB, et al. Latent tuberculosis infection in transplant candidates: a systematic review and meta-analysis on TST and IGRA. Infection. 2019;47(3):353–61. Epub 2019/02/26. doi: 10.1007/s15010-019-01285-7 30805899.

31. JafariNezhad A, YektaKooshali MH. Lung cancer in idiopathic pulmonary fibrosis: A systematic review and meta-analysis. PLoS One. 2018;13(8):e0202360. Epub 2018/08/17. doi: 10.1371/journal.pone.0202360 30114238.

32. da Costa Santos CM, de Mattos Pimenta CA, Nobre MR. The PICO strategy for the research question construction and evidence search. Rev Lat Am Enfermagem. 2007;15(3):508–11. Epub 2007/07/27. doi: 10.1590/s0104-11692007000300023 17653438.

33. Krajewski W, Zdrojowy R, Grzegolka J, Krajewski P, Wrobel M, Luczak M, et al. Does Mantoux Test Result Predicts BCG Immunotherapy Efficiency and Severe ToXxicity in Non-Muscle Invasive Bladder Cancer. Urology journal. 2018. Epub 2018/11/25. doi: 10.22037/uj.v0i0.4542 30471076.

34. Sargin G, Senturk T, Ceylan E, Telli M, Cildag S, Dogan H. TST, QuantiFERON-TB Gold test and T-SPOT.TB test for detecting latent tuberculosis infection in patients with rheumatic disease prior to anti-TNF therapy. Tuberkuloz ve toraks. 2018;66(2):136–43. Epub 2018/09/25. doi: 10.5578/tt.66444 30246657.

35. Wang W, Liu HM, Zhou J, Wang YG, Feng X, Tang H, et al. Skin test of tuberculin purified protein derivatives with a dissolving microneedle-array patch. Drug delivery and translational research. 2019. Epub 2019/03/21. doi: 10.1007/s13346-019-00629-y 30891708.

36. Wigg AJ, Narayana SK, Anwar S, Ramachandran J, Muller K, Chen JW, et al. High rates of indeterminate interferon-gamma release assays for the diagnosis of latent tuberculosis infection in liver transplantation candidates. Transpl Infect Dis: an official journal of the Transplantation Society. 2019:e13087. Epub 2019/03/31. doi: 10.1111/tid.13087 30927483.

37. Barton E, Gao Y, Ball D, Fidler K, Klein N, Curtis N, et al. Calcineurin Inhibitors and Variation in the Performance of Interferon-gamma Release Assays Used to Detect Tuberculosis Infection. Annals of the American Thoracic Society. 2019;16(6):771–5. Epub 2019/02/28. doi: 10.1513/AnnalsATS.201811-784RL 30811214.

38. Bennet R, Nejat S, Eriksson M. Effective Tuberculosis Contact Investigation Using Interferon-Gamma Release Assays. The Pediatric infectious disease journal. 2019;38(4):e76–e8. Epub 2019/03/19. doi: 10.1097/INF.0000000000002272 30882747.

39. Igari H, Akutsu N, Ishikawa S, Aoyama H, Otsuki K, Hasegawa M, et al. Positivity rate of interferon-gamma release assays for estimating the prevalence of latent tuberculosis infection in renal transplant recipients in Japan. J Infect Chemother: official journal of the Japan Society of Chemotherapy. 2019. Epub 2019/03/25. doi: 10.1016/j.jiac.2019.02.018 30905632.

40. Poorolajal J, Cheraghi Z, Irani AD, Rezaeian S. Quality of Cohort Studies Reporting Post the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement. Epidemiol Health. 2011;33:e2011005. Epub 2011/07/01. doi: 10.4178/epih/e2011005 21716598.

41. Ades AE, Lu G, Higgins JP. The interpretation of random-effects meta-analysis in decision models. Med Decis Making. 2005;25(6):646–54. Epub 2005/11/12. doi: 10.1177/0272989X05282643 16282215.

42. Borenstein M, Hedges LV, Higgins JP, Rothstein HR. A basic introduction to fixed-effect and random-effects models for meta-analysis. Res Synth Methods. 2010;1(2):97–111. Epub 2010/04/01. doi: 10.1002/jrsm.12 26061376.

43. Alian S, Dadashi A, Najafi N, Alikhani A, Davoudi A, Moosazadeh M, et al. Evaluation of Tuberculin Skin Test (TST) in Medical Students in Mazandaran University of Medical Sciences, Sari, Iran. Global Journal of Health Science. 2016;9(5):274.

44. Besharat M, Abbasi F. Tuberculin Skin Test among 1,424 Healthy Employees in Chaharmahal Province, Iran. Tanaffos. 2011;1(10):37–9.

45. Davoodi L, Babamahmoodi F, Mirabi A, Mohammad Hosseini E. Evaluation of Tuberculin Skin Test Seroconversion Among the Staff in Qaemshahr Razi Hospital, 2015–2017. Journal of Mazandaran University of Medical Sciences. 2018;28(164):158–63.

46. Ghafouri M, Seyed Sharifi S. Prevalence of latent tuberculosis infections in Health care workers (HCW) in Mashhad Hospital. J North Khorasan Univ Med Sci. 2015;6(4):829–40.

47. Golchin M, Rostami M. Tuberculin test in nursing and human-sciences students. Journal of Research in Medical Sciences. 2005;10(3):172–6.

48. Hashemi SH, Mamani M, Alizadeh N, Nazari M, Sedighi I. Prevalence of tuberculosis infection among health-care workers in Hamadan, west of Iran. Avicenna J Clin Microbiol Infect. 2014;1(1):e19214.

49. Kariminia A, Sharifnia Z, Aghakhani A, Banifazl M, Eslamifar A, Hazrati M, et al. Comparison of QuantiFERON TB-G-test to TST for detecting latent tuberculosis infection in a high-incidence area containing BCG-vaccinated population. Journal of evaluation in clinical practice. 2009;15(1):148–51. Epub 2009/02/26. doi: 10.1111/j.1365-2753.2008.00970.x 19239595.

50. Mostafavi E, Nasehi M, Hashemi Shahraki A, Esmaeili S, Ghaderi E, Sharafi S, et al. Comparison of the tuberculin skin test and the QuantiFERON-TB Gold test in detecting latent tuberculosis in health care workers in Iran. Epidemiol Health. 2016;38:e2016032. Epub 2016/07/28. doi: 10.4178/epih.e2016032 27457062.

51. Nasehi M, Hashemi-Shahraki A, Doosti-Irani A, Sharafi S, Mostafavi E. Prevalence of latent tuberculosis infection among tuberculosis laboratory workers in Iran. Epidemiol Health. 2017;39:e2017002. Epub 2017/01/18. doi: 10.4178/epih.e2017002 28092930.

52. Nazer M, Shahivand M, Zare S. The prevalence of latent tuberculosis (TB) infection in healthcare staff of Khorramabad Ashayer hospital in 2015. Yafte. 2015;17(2):23–31.

53. Nikokar I, Dadgran A, Mafozei L. A comparison of two-step tuberculin skin test between health-care workers and nonhospital employees. Iranian Journal of Medical Sciences. 2015;35(3):201–4.

54. Rahbar M, Karamyar M, Hajia M. Prevalence and determinant of tuberculin skin test among health care workers of Imam Khomeini Hospital of Uremia, Iran. Shiraz E-Medical Journal. 2007;8(4):162–7.

55. Salehi M, Mood BS, Metanat M. Positive Tuberculin Skin Test Among Health Care Workers: Prevalence and Risk Factors in Teaching Hospitals of a Highly Endemic Region for Tuberculosis, Zahedan, Iran. Int J Infect. 2016;3(3).

56. Salmanzadeh S, Abbasissifar H, Alavi SM. Comparison study of QuantiFERON test with tuberculin skin testing to diagnose latent tuberculosis infection among nurses working in teaching hospitals of Ahvaz, Iran. Caspian journal of internal medicine. 2016;7(2):82–7. Epub 2016/07/08. 27386058.

57. Sayad B, Zarpeyma A, Janbakhsh A. Tuberculin Skin Test Results in Health Care Workers of Imam Khomeini Hospital (Kermanshah 2004). J Kermamnshah Univ Med Sci (Behbood). 2006;10(3):258–67.

58. Sharafkhani R, Ahmadi N, Salarilak S, Rahimirad M, Khashabi J. prevalence of tuberculosis infection in health and office workers at Urmia University of Medical Sciences. J Urmia Univ Med Sci. 2011;22(2):119–22.

59. Taheri M, Bazrafkan H, Habibagahi M. Determining the Latent Tuberculosis Infection by IFN—gamma Elispot Assay in Healthcare Workers from University Hospitals of Shiraz, South West of Iran. Iran Red Crescent Med J. 2013;15(6):477–82. Epub 2013/12/19. doi: 10.5812/ircmj.3635 24349745.

60. Talebi-Taher M, Javad-Moosavi SA, Entezari AH, Shekarabi M, Parhizkar B. Comparing the performance of QuantiFERON-TB Gold and Mantoux test in detecting latent tuberculosis infection among Iranian health care workers. Int J Occup Med Environ Health. 2011;24(4):359–66. Epub 2011/11/17. doi: 10.2478/s13382-011-0046-7 22086450.

61. Tavanaee Sani A, Hajian S, Maryam S. Evaluation of PPD test in Medical Student of Mashhad University Medical Sciences in 2011–2013. Med J Mashhad Univ of Med Sci. 2015;58(8):441–5.

62. Vaziri S, Khazaei S, Neishaboori S, Kanani M, Madani S. The degree of agreement of quantiferon TB gold test and tuberculin skin test in nurses. J Gorgan Univ Med Sci. 2011;13(1):37–43.

63. Agaya J, Nnadi CD, Odhiambo J, Obonyo C, Obiero V, Lipke V, et al. Tuberculosis and latent tuberculosis infection among healthcare workers in Kisumu, Kenya. Trop Med Int Health. 2015;20(12):1797–804. doi: 10.1111/tmi.12601 26376085.

64. Corbett EL, Marston B, Churchyard GJ, De Cock KM. Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatment. Lancet. 2006;367(9514):926–37. Epub 2006/03/21. doi: 10.1016/S0140-6736(06)68383-9 16546541.

65. Drobniewski F, Cooke M, Jordan J, Casali N, Mugwagwa T, Broda A, et al. Systematic review, meta-analysis and economic modelling of molecular diagnostic tests for antibiotic resistance in tuberculosis. Health Technol Assess. 2015;19(34):1–188, vii–viii. Epub 2015/05/09. doi: 10.3310/hta19340 25952553.

66. Franco C, Zanetta D JTIJoT, Disease L. Assessing occupational exposure as risk for tuberculous infection at a teaching hospital in Sao Paulo, Brazil. Int J Tuberc Lung Dis. 2006;10(4):384–9. 16602401.

67. Powell K, Han D, Hung N, Vu T, Sy D, Trinh T, et al. Prevalence and risk factors for tuberculosis infection among personnel in two hospitals in Viet Nam. Int J Tuberc Lung Dis. 2011;15(12):1643–9. doi: 10.5588/ijtld.11.0207 22118172.

68. Rutanga C, Lowrance DW, Oeltmann JE, Mutembayire G, Willis M, Uwizeye CB, et al. Latent tuberculosis infection and associated factors among Health Care Workers in Kigali, Rwanda. PLoS One.2015;10(4):e0124485. doi: 10.1371/journal.pone.0124485 25919759.

69. Zhu S, Xia L, Yu S, Chen S, Zhang J. The burden and challenges of tuberculosis in China: findings from the Global Burden of Disease Study 2015. Sci Rep. 2017;7(1):14601. Epub 2017/11/04. doi: 10.1038/s41598-017-15024-1 29097809.

70. van Rie A, Beyers N, Gie RP, Kunneke M, Zietsman L, Donald PR. Childhood tuberculosis in an urban population in South Africa: burden and risk factor. Arch Dis Child. 1999;80(5):433–7. Epub 1999/04/20. doi: 10.1136/adc.80.5.433 10208948.

71. Durando P, Sotgiu G, Spigno F, Piccinini M, Mazzarello G, Viscoli C, et al. Latent tuberculosis infection and associated risk factors among undergraduate healthcare students in Italy: a cross-sectional study. BMC Infectious Diseases. 2013;13(1):443.

72. Storla DG, Yimer S, Bjune GA. A systematic review of delay in the diagnosis and treatment of tuberculosis. BMC Public Health. 2008;8(1):15. Epub 2008/01/16. doi: 10.1186/1471-2458-8-15 18194573.

73. Prasad R, Singh A, Balasubramanian V, Gupta N. Extensively drug-resistant tuberculosis in India: Current evidence on diagnosis & management. Indian J Med Res. 2017;145(3):271–93. Epub 2017/07/28. 28749390.

74. Nasreen S, Shokoohi M, Malvankar-Mehta MS JPo. Prevalence of latent tuberculosis among health care workers in high burden countries: a systematic review and meta-analysis. PLoS One. 2016;11(10):e0164034. doi: 10.1371/journal.pone.0164034 27711155.

75. Apriani L, McAllister S, Sharples K, Alisjahbana B, Ruslami R, Hill PC, et al. Latent tuberculosis infection in health care workers in low and middle-income countries: an updated systematic review. Eur Respir J. 2019; 18;53(4):1801789. doi: 10.1183/13993003.01789-2018 30792341

76. Karadakhy K, Othman N, Ibrahimm F, Saeed AA, Amin AAH. Tuberculosis in Sulaimaniyah, Iraqi Kurdistan: A Detailed Analysis of Cases Registered in Treatment Centers. Tanaffos. 2016;15(4):197–204. Epub 2016/01/01. 28469675.

77. Hassan DN, Hanna AJ. Tuberculosis and sudden death in Baghdad. Am J Forensic Med Pathol. 1984;5(2):169–74. Epub 1984/06/01. doi: 10.1097/00000433-198406000-00013 6731410.

78. Sargazi A, Sepehri Z, Sagazi A, Jim PN, Kiani Z JAr, control i. Eastern Mediterranean region tuberculosis economic burden in 2014. Antimicrob Resist Infect Control. 2015;4(1):P102. doi: 10.1186/2047-2994-4-S1-P102

79. Sahebi L, Ansarin K, Maryam S, Monfaredan A, Sabbgh Jadid H. The factors associated with tuberculosis recurrence in the northwest and west of iran. Malays J Med Sci. 2014;21(6):27–35. Epub 2015/04/22. 25897280.

80. Jimma W, Ghazisaeedi M, Shahmoradi L, Abdurahman AA, Kalhori SRN, Nasehi M, et al. Prevalence of and risk factors for multidrug-resistant tuberculosis in Iran and its neighboring countries: systematic review and meta-analysis. Rev Soc Bras Med Trop. 2017;50(3):287–95. Epub 2017/07/13. doi: 10.1590/0037-8682-0002-2017 28700044.

81. Rezai MS, Abedi S, Afshari M, Moosazadeh M JOph, perspectives r. Estimating tuberculin skin test reactions among children and teenagers who received the bacillus Calmette-Guerin vaccination at birth: A meta-analysis. Osong Public Health Res Perspect. 2017;8(1):3–10. doi: 10.24171/j.phrp.2017.8.1.02 28443219

82. Goscé L, Bitencourt J, Gupta R, Arruda S, Rodrigues L, Abubakar I JIJoID. BCG vaccination following latent TB treatment: Possible implications for different settings. Int J Infect Dis. 2019;80:S17–S9. doi: 10.1016/j.ijid.2019.02.026 30818048.

83. Al-Orainey IO JAotm. Diagnosis of latent tuberculosis: Can we do better? Ann Thorac Med. 2009;4(1):5–10. doi: 10.4103/1817-1737.44778 19561914


Článek vyšel v časopise

PLOS One


2019 Číslo 10

Nejčtenější v tomto čísle

Tomuto tématu se dále věnují…


Kurzy

Zvyšte si kvalifikaci online z pohodlí domova

Léčba bolesti v ordinaci praktického lékaře
nový kurz
Autoři: MUDr. PhDr. Zdeňka Nováková, Ph.D.

Revmatoidní artritida: včas a k cíli
Autoři: MUDr. Heřman Mann

Jistoty a nástrahy antikoagulační léčby aneb kardiolog - neurolog - farmakolog - nefrolog - právník diskutují
Autoři: doc. MUDr. Štěpán Havránek, Ph.D., prof. MUDr. Roman Herzig, Ph.D., doc. MUDr. Karel Urbánek, Ph.D., prim. MUDr. Jan Vachek, MUDr. et Mgr. Jolana Těšínová, Ph.D.

Léčba akutní pooperační bolesti
Autoři: doc. MUDr. Jiří Málek, CSc.

Nové antipsychotikum kariprazin v léčbě schizofrenie
Autoři: prof. MUDr. Cyril Höschl, DrSc., FRCPsych.

Všechny kurzy
Kurzy Doporučená témata Časopisy
Přihlášení
Zapomenuté heslo

Nemáte účet?  Registrujte se

Zapomenuté heslo

Zadejte e-mailovou adresu se kterou jste vytvářel(a) účet, budou Vám na ni zaslány informace k nastavení nového hesla.

Přihlášení

Nemáte účet?  Registrujte se